Bright Minds Biosciences (DRUG) EBIAT (2020 - 2026)
Bright Minds Biosciences (DRUG) has disclosed EBIAT for 2 consecutive years, with -$7.6 million as the latest value for Q1 2026.
- EBIAT reached -$7.6 million in Q1 2026 per DRUG's latest filing, down from -$2.2 million in the prior quarter.
- Across five years, EBIAT topped out at -$7.6 million in Q1 2026 and bottomed at -$7.6 million in Q1 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | -2.99 Mn |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 30.90 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | -14.46 Mn |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 1.03 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 727.20 Mn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | -3.63 Mn |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 205.99 Mn |
| 10 | Bright Minds Biosciences | 464.72 Mn | 405.19 Mn | - | -7.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.63 Mn |
| Dec 31, 2025 | -5.42 Mn |
| Sep 30, 2025 | -2.97 Mn |
| Jun 30, 2025 | -3.78 Mn |
| Mar 31, 2025 | -2.06 Mn |
| Dec 31, 2024 | 35,513.28 |
| Sep 30, 2024 | 566,973.56 |
| Jun 30, 2024 | 168,091.41 |
| Mar 31, 2024 | -426,077.62 |
| Dec 31, 2023 | -1.24 Mn |
| Sep 30, 2023 | -1.07 Mn |
| Jun 30, 2023 | -1.09 Mn |
| Mar 31, 2023 | -1.52 Mn |
| Dec 31, 2022 | -1.72 Mn |
| Sep 30, 2022 | 2.27 Mn |
| Jun 30, 2022 | 2.09 Mn |
| Mar 31, 2022 | 3.54 Mn |
| Dec 31, 2021 | 3.85 Mn |
| Sep 30, 2021 | -11.47 Mn |
| Jun 30, 2021 | 2.87 Mn |
| Mar 31, 2021 | 1.25 Mn |
| Dec 31, 2020 | 519,339.73 |
| Sep 30, 2020 | -418,839.97 |